PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
AXLA vs. OLMA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

AXLA vs. OLMA

Last updated May 13, 2025

Compare and contrast key facts about Axcella Health Inc. (AXLA) and Olema Pharmaceuticals, Inc. (OLMA).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AXLA or OLMA.

Correlation

The correlation between AXLA and OLMA is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

AXLA vs. OLMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Axcella Health Inc. (AXLA) and Olema Pharmaceuticals, Inc. (OLMA). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

AXLA:

$1.18M

OLMA:

$314.46M

EPS

AXLA:

-$18.25

OLMA:

-$2.20

PS Ratio

AXLA:

0.00

OLMA:

0.00

PB Ratio

AXLA:

19.10

OLMA:

0.77

Returns By Period

AXLA

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

OLMA

YTD

-18.35%

1M

26.26%

6M

-62.58%

1Y

-48.93%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

AXLA vs. OLMA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
AXLA
OLMA
The Risk-Adjusted Performance Rank of OLMA is 1515
Overall Rank
The Sharpe Ratio Rank of OLMA is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of OLMA is 1414
Sortino Ratio Rank
The Omega Ratio Rank of OLMA is 1515
Omega Ratio Rank
The Calmar Ratio Rank of OLMA is 1212
Calmar Ratio Rank
The Martin Ratio Rank of OLMA is 1818
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AXLA vs. OLMA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Axcella Health Inc. (AXLA) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

No data
No data
No data
No data

Loading data...

Dividends

AXLA vs. OLMA - Dividend Comparison

Neither AXLA nor OLMA has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

AXLA vs. OLMA - Drawdown Comparison

Loading data...

Volatility

AXLA vs. OLMA - Volatility Comparison

Loading data...

Financials

AXLA vs. OLMA - Financials Comparison

This section allows you to compare key financial metrics between Axcella Health Inc. and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.00500.00K1.00M1.50M2.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober00
(AXLA) Total Revenue
(OLMA) Total Revenue
Values in USD except per share items